Process for the synthesis of efinaconazol
Disclosed is a process for the synthesis of efinaconazole (I), starting from 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole and 4-methylenepiperidine, as free base or hydrochloride, in an organic solvent, under anhydrous conditions and in the presence of neutralising agents and reaction-promoting metal species. (1) The process is particularly advantageous because it gives rise to efinaconazole in high yields and purity, and uses little more than the stoichiometric amount of 4-methylenepiperidine, a rather expensive commercially available reagent.
1. A process for the synthesis of efinaconazole which comprises reacting 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxyranyl]methyl]-1H-1,2,4-triazole with 4-methylenepiperidine hydrochloride, in an organic aprotic solvent in the presence of neutralising agents and metal species promoting the reaction under anhydrous conditions, wherein said neutralizing agent is isopropylmagnesium chloride.
2. The process according to claim 1 wherein the organic aprotic solvent is acetonitrile or tetrahydrofuran or 2-methyltetrahydrofuran.
3. The process according to claim 1 wherein the agent promoting the opening of the epoxide ring are selected from alkylmagnesium halides and anhydrous magnesium chloride.
4. A process for the synthesis of efinaconazole which comprises reacting 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxyranyl]methyl]-1H-1,2,4-triazole with 4-methylenepiperidine, in an organic aprotic solvent in the presence of neutralising agents and metal species promoting the reaction under anhydrous conditions, wherein the neutralising agents are selected from organic amines and proton acceptors.
5. The process according to claim 4 wherein the neutralising agent is N,N-diisopropylethylamine and isopropylmagnesium bromide.